• Necrostatin 2: Mapping Cell Death at Membranes

  2026-08-29

  Necrostatin 2 (Nec-2) is a mechanistic probe for necroptosis inhibition and RIPK2-linked signaling. This guide connects pathway-selective perturbation with membrane-level ferroptosis biology to improve assay interpretation without confusing distinct forms of cell death.

• Salvianolic acid B: Designing Better Fibrosis Assays

  2026-08-28

  Salvianolic acid B, also called Dan Shen Suan B, is more than a general antioxidant in pulmonary fibrosis research. This article presents a matrix-centered framework for connecting LH2 expression, collagen maturation, tissue architecture, and assay design while identifying the evidence gaps that remain.

• THZ1 for Reproducible CDK7 Cell Assays

  2026-08-28

  A scenario-based guide to using THZ1 (SKU A8882) in cell viability, proliferation, cytotoxicity, and transcription-focused experiments. It explains mechanism, concentration planning, solvent and storage controls, interpretation of apoptosis assays, and practical supplier-selection criteria.

• Cyanidin Chloride: Identity-First Antioxidant Research

  2026-08-27

  Cyanidin Chloride can support rigorous oxidative stress research when chemical identity, redox assay behavior, and cellular endpoints are interpreted together. This article develops an identity-first workflow that distinguishes product-specific evidence from related anthocyanin findings.

• Doxorubicin: A Cardiotoxicity-Aware Research Framework

  2026-08-27

  Doxorubicin and Adriamycin remain indispensable cancer research tools, but their value increases when tumor efficacy and cardiac liability are measured together. This guide translates recent mitochondrial cardioprotection findings into practical, better-controlled assay decisions.

• Salvianolic Acid B, LH2, and Pulmonary Fibrosis

  2026-08-26

  The reference study identifies Salvianolic acid B, also known as Dan Shen Suan B, as an antifibrotic agent that lowers lysyl hydroxylase 2 expression and collagen cross-linking in pulmonary fibrosis models. By combining cellular perturbation with tissue-level evaluation, the work positions LH2-associated matrix modification as a mechanistically important target while leaving direct binding, selectivity, and clinical translation unresolved.

• Position-3 Design in Degarelix GnRH Antagonists

  2026-08-26

  Samant et al. examined how replacing the position-3 residue of degarelix with 3-(2-methoxy-5-pyridyl)-alanine changes GnRH receptor antagonism and duration of action. The study shows that stereochemistry can preserve in vitro potency while failing to preserve in vivo persistence, providing a useful structure–activity lesson for peptide lead optimization.

• Salvianolic acid B for Pulmonary Fibrosis Assays

  2026-08-25

  Salvianolic acid B provides a mechanism-led way to study LH2-associated collagen remodeling rather than relying on nonspecific fibrosis readouts alone. This workflow combines dose finding, viability controls, molecular profiling, and matrix-level validation for more defensible pulmonary fibrosis experiments.

• γH2AX DNA Damage Detection Kit: From Foci to Function

  2026-08-25

  The γH2AX DNA Damage Detection Kit transforms DNA double-strand break staining into a time-resolved framework for interpreting repair, apoptosis, and radiosensitization. This article connects γ-H2AX imaging with the FLASH-RT nanoparticle study and practical assay design decisions.

• Phenacetin for Translational PK Workflows

  2026-08-24

  Phenacetin offers a practical, research-only probe for connecting compound handling, intestinal absorption models, and pharmacokinetic studies. Its defined solubility profile and analytical identity make it useful for workflow benchmarking, while careful controls are essential because it is not a PDK4 inhibitor or a medical product.

• γH2AX DNA Damage Detection Kit Workflow

  2026-08-23

  Turn radiation, nanoparticle, and genotoxicity experiments into spatially resolved DNA double-strand break data with a red-fluorescent γ-H2AX workflow. This guide connects assay setup, quantitative imaging, FLASH-RT study design, and troubleshooting for more reproducible damage-and-repair measurements.

• Palonosetron for Chemotherapy-Induced Nausea and Vomiting

  2026-08-22

  Ruhlmann and Herrstedt review how palonosetron differs pharmacologically from earlier 5-HT3 receptor antagonists and assess whether those differences translate into better prevention of chemotherapy-induced nausea and vomiting. The paper highlights palonosetron’s prolonged exposure, high receptor affinity, and potential value in delayed emesis while emphasizing that pharmacologic novelty must be judged against clinical efficacy, tolerability, and combination-based antiemetic practice.

• 4-Hydroxytamoxifen Protocol and QC Guide

  2026-08-21

  This guide explains how to prepare, control, and troubleshoot 4-Hydroxytamoxifen for DMSO-based research workflows, including estrogen receptor studies, cancer models, apoptosis assays, and cardiac myocyte calcium handling studies. It is not suitable for protocols requiring water- or ethanol-based solubilization, and no directly matched paper evidence was supplied for a universal dose, timing, or endpoint.

• EGCG Nanoparticles Improve FLASH-RT Antitumor Efficacy

  2026-08-21

  A 2026 study reports that functionalized, self-assembled epigallocatechin gallate nanoparticles, termed BENPs, can amplify FLASH radiotherapy-induced oxidative stress, tumor-cell death, and antitumor immune activation in preclinical models. The work provides a framework for connecting DNA damage measurements with immune and safety endpoints when evaluating radiosensitizers for ultra-high-dose-rate radiotherapy.

• KJG and the TLR4/PI3K/AKT/FOXO1 Axis in Depression

  2026-08-20

  This study combines chemical profiling, network pharmacology, molecular docking, and experimental validation to show that Kaixin Jieyu Granule may reduce neuroinflammation-associated depressive-like behavior through TLR4/PI3K/AKT/FOXO1 signaling. Its use of both chronic stress and inflammatory models, together with pharmacological pathway perturbation, provides a useful framework for connecting multicomponent traditional medicine with testable molecular mechanisms.

461 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page